Mylan, Ranbaxy Slam Bid To Change Provigil Class Cert.
Generic-drug makers Mylan Pharmaceuticals Inc. and Ranbaxy Pharmaceuticals Inc. have urged a Pennsylvania federal judge to reject a request by direct buyers of Provigil to modify a class certification order in...To view the full article, register now.
Already a subscriber? Click here to view full article